IL186545A0 - Method for characterizing the transactivation and transgression activity or glucocorticoid receptor ligands in primary immune cells - Google Patents
Method for characterizing the transactivation and transgression activity or glucocorticoid receptor ligands in primary immune cellsInfo
- Publication number
- IL186545A0 IL186545A0 IL186545A IL18654507A IL186545A0 IL 186545 A0 IL186545 A0 IL 186545A0 IL 186545 A IL186545 A IL 186545A IL 18654507 A IL18654507 A IL 18654507A IL 186545 A0 IL186545 A0 IL 186545A0
- Authority
- IL
- Israel
- Prior art keywords
- transgression
- transactivation
- characterizing
- activity
- immune cells
- Prior art date
Links
- 102000003676 Glucocorticoid Receptors Human genes 0.000 title 1
- 108090000079 Glucocorticoid Receptors Proteins 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 title 1
- 210000004990 primary immune cell Anatomy 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Endocrinology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005020711 | 2005-04-29 | ||
| US67999305P | 2005-05-12 | 2005-05-12 | |
| PCT/EP2006/004409 WO2006117242A2 (de) | 2005-04-29 | 2006-05-02 | Verfahren zur charakterisierung der transaktivierungs- und transrespressionsaktivität von glukokortikoidrezeptor-liganden in primären immunzellen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL186545A0 true IL186545A0 (en) | 2008-01-20 |
Family
ID=36675955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL186545A IL186545A0 (en) | 2005-04-29 | 2007-10-10 | Method for characterizing the transactivation and transgression activity or glucocorticoid receptor ligands in primary immune cells |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1877803A2 (de) |
| JP (1) | JP2008538903A (de) |
| KR (1) | KR20080014753A (de) |
| AU (1) | AU2006243359A1 (de) |
| CA (1) | CA2605011A1 (de) |
| IL (1) | IL186545A0 (de) |
| MX (1) | MX2007013504A (de) |
| NO (1) | NO20076140L (de) |
| WO (1) | WO2006117242A2 (de) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7622260B2 (en) * | 2001-09-05 | 2009-11-24 | The Brigham And Women's Hospital, Inc. | Diagnostic and prognostic tests |
-
2006
- 2006-05-02 MX MX2007013504A patent/MX2007013504A/es not_active Application Discontinuation
- 2006-05-02 WO PCT/EP2006/004409 patent/WO2006117242A2/de not_active Ceased
- 2006-05-02 EP EP06753555A patent/EP1877803A2/de not_active Withdrawn
- 2006-05-02 AU AU2006243359A patent/AU2006243359A1/en not_active Abandoned
- 2006-05-02 KR KR1020077024790A patent/KR20080014753A/ko not_active Withdrawn
- 2006-05-02 JP JP2008508172A patent/JP2008538903A/ja active Pending
- 2006-05-02 CA CA002605011A patent/CA2605011A1/en not_active Abandoned
-
2007
- 2007-10-10 IL IL186545A patent/IL186545A0/en unknown
- 2007-11-28 NO NO20076140A patent/NO20076140L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2605011A1 (en) | 2006-11-09 |
| KR20080014753A (ko) | 2008-02-14 |
| WO2006117242A2 (de) | 2006-11-09 |
| EP1877803A2 (de) | 2008-01-16 |
| AU2006243359A8 (en) | 2006-11-09 |
| NO20076140L (no) | 2007-11-28 |
| WO2006117242A3 (de) | 2007-04-26 |
| JP2008538903A (ja) | 2008-11-13 |
| MX2007013504A (es) | 2008-01-11 |
| AU2006243359A1 (en) | 2006-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200804868B (en) | Anti-OX40L antibodies and methods using same | |
| EP1807229A4 (de) | Gekrümmte wabenstruktur und verfahren zu ihrer verarbeitung | |
| ZA200700836B (en) | Breadmaking methods and products | |
| IL178356A0 (en) | Dr5 antibodies and uses thereof | |
| ZA200606859B (en) | Aircraft seating and seating arrangements | |
| EP2182980A4 (de) | Verfahren und zusammensetzungen für erhöhte alpha-iduronidase-aktivität im zns | |
| LT2479259T (lt) | Daug kartų kriokonservuoti hepatocitai ir jų paruošimo būdai | |
| GB0720092D0 (en) | Improvements in bus stops and bus shelters | |
| SI1973950T1 (sl) | Anti-EphB4 protitelesa in postopki njihove uporabe | |
| GB0605702D0 (en) | Materials and methods for immune cell stimulation | |
| TWI316258B (en) | Adjustable delay cells and delay lines including the same | |
| GB0414826D0 (en) | Particulate | |
| ZA200710335B (en) | Method for characterizing the transactivation and transgression activity of glucocorticoid receptor ligands in primary immune cells | |
| GB2411985B (en) | Bus arrangement and method thereof | |
| GB2413131B (en) | Composite particles | |
| GB0412015D0 (en) | Building framework method for making the same and components used in the framework | |
| GB0706420D0 (en) | Laminate material testing methods and systems | |
| PT1883647E (pt) | Oligonucleótido e composições compreendendo o mesmo para o tratamento de neoplasma de células | |
| EP1829436A4 (de) | Anionische und neutrale teilchenstrahlen | |
| IL177070A0 (en) | Compositions containing particulate plant sterols and processes for the preparation thereof | |
| ZA200708254B (en) | Viral diagnostic method and well for use in same | |
| IL186545A0 (en) | Method for characterizing the transactivation and transgression activity or glucocorticoid receptor ligands in primary immune cells | |
| ZA200704988B (en) | Particulate materials | |
| GB2417688B (en) | Improvements in and relating to neurostimulation | |
| IL181903A0 (en) | Irta-4 antibodies and their uses |